The Journal of Nutritional Biochemistry
Volume 21, Issue 2 , Pages 77-88 , February 2010

Mouse models for unraveling the importance of diet in colon cancer prevention

  • Alexandra E. Tammariello

      Affiliations

    • Department of Human Nutrition, Foods and Exercise, Virginia Tech, Blacksburg, VA, USA
  • ,
  • John A. Milner

      Affiliations

    • Nutritional Science Research Group, Division of Cancer Prevention, National, Cancer Institute, National Institutes of Health, Health and Human Services, Rockville, MD 20892, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 301 496 0118; fax: +1 301 480 3925.

Received 2 February 2009 ,Revised 30 July 2009 ,Accepted 21 September 2009.

References 

  1. Greenlee R, Hill-Harmon M, Murray T, Thun M. Cancer Statistics, 2001. CA Cancer J Clin. 2001;51:15–36
  2. National Cancer Institute . "Finding Statistics." National Cancer Institute Surveillance Epidemiology and End Results. National Institutes of Health; 2008;04 June 2008 http://seer.cancer.gov/statfacts/html/colorect.html
  3. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66(6):1191–1308[Review]
  4. World Cancer Research Fund/ American Institute for Cancer Research . Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington (DC): AICR; 2007;
  5. Levi F, Pasche C, Lucchini F, La Vecchia C. Dietary fibre and the risk of colorectal cancer. Eur J Cancer. 2001;37(16):2091–2096
  6. Franceschi S, Parpinel M, La Vecchia C, Favero A, Talamini R, Negri E. Role of different types of vegetables and fruit in the prevention of cancer of the colon, rectum, and breast. Epidemiology. 1998;9(3):338–341
  7. Kesse E, Boutron-Ruault MC, Norat T, Riboli E, Clavel-Chapelon F E3N Group. Dietary calcium, phosphorus, vitamin D, dairy products and the risk of colorectal adenoma and cancer among French women of the E3N-EPIC prospective study. Int J Cancer. 2005;117(1):137–144
  8. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985;1(8424):307–309
  9. Singh PN, Fraser GE. Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol. 1998;148(8):761–774
  10. Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD, et al. Meat consumption and risk of colorectal cancer. JAMA. 2005;293(2):172–182
  11. Murata M, Takayama K, Choi BC, Pak AW. A nested case-control study on alcohol drinking, tobacco smoking, and cancer. Cancer Detect Prev. 1996;20(6):557–565
  12. Fodde R. The APC gene in colorectal cancer. Eur J Cancer. 2002;38(7):867–871
  13. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Molecular biology of colorectal cancer. Curr Probl Cancer. 1997;21(5):233–300
  14. Strachan T, Read AP. Human Molecular Genetics 2. 2nd ed.. USA: John Wiley & Sons Inc.; 1999;
  15. Schoental R, Bensted JPM. Gastro-intestinal tumours in rats and mice following various routes of administration of N-methyl-N-nitroso-N′-nitroguanidine and N-ethyl-N-Nitroso-N′-nitroguanidine. British J Canc. 1969;23:757–764
  16. Colussi C, Fiumicino S, Giuliani A, Rosini S, Musiani P, Macri C, et al. 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. J Natl Cancer Inst. 2001;93(20):1534–1540
  17. Fujita H, Nagano K, Ochiai M, Ushijima T, Sugimura T, Nagao M, et al. Difference in target organs in carcinogenesis with a heterocyclic amine, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, in different strains of mice. Jap J Cancer Res. 1999;90:1203–1206
  18. Qin X, Shibata D, Gerson SL. Heterozygous DNA mismatch repair gene Pms2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea. Carcinogenesis. 2000;21:833–838
  19. Gold LS, Manley NB, Slone TH, Ward JM. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol Pathol. 2001;29:639–652
  20. Corpet DE, Pierre F. Point: From Animal Models to Prevention of Colon Cancer. Systematic Review of Chemoprevention in Min Mice and Choice of the Model System. Cancer Epidemiology. 2003;12:391–400
  21. Corpet DE, Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur J Cancer. 2005;41(13):1911–1922
  22. Chen J, Roop DR. Genetically engineered mouse models for skin research: taking the next step. J Dermatol Sci. 2008;52(1):1–12
  23. Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T. Transforming growth factor b1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res. 1999;59:3379–3386
  24. Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell. 1998;94:703–714
  25. Taketo MM, Edelmann W. Mouse Models of Colon Cancer. Gastroenterology. 2009;136:780–798
  26. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990;247(4940):322–324
  27. Smits R, Kielman MF, Breukel C, Zurcher C, Neufeld K, Jagmohan-Changur S, et al. Apc1638T: A mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev. 1999;13:1309–1321
  28. Misikangas M, Pajari AM, Päivärinta E, Oikarinen SI, Rajakangas J, Marttinen M, et al. Three Nordic berries inhibit intestinal tumorigenesis in multiple intestinal neoplasia/+ mice by modulating beta-catenin signaling in the tumor and transcription in the mucosa. J Nutr. 2007;137(10):2285–2290
  29. Kennedy AR, Beazer-Barclay Y, Kinzler KW, Newberne PM. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res. 1996;56(4):679–682
  30. Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, Martucci C, et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis. 2000;21(5):921–927
  31. Mai V, Colbert LH, Berrigan D, Perkins SN, Pfeiffer R, Lavigne JA, et al. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res. 2003;63(8):1752–1755
  32. Yu CF, Whiteley L, Carryl O, Basson MD. Differential dietary effects on colonic and small bowel neoplasia in C57BL/6J Apc Min/+ mice. Dig Dis Sci. 2001;46(7):1367–1380
  33. Niho N, Mutoh M, Sakano K, Takahashi M, Hirano S, Nukaya H, et al. Inhibition of intestinal carcinogenesis by a new flavone derivative, chafuroside, in oolong tea. Cancer Sci. 2006;97(4):248–251
  34. Davis CD, Newman S. Inadequate dietary copper increases tumorigenesis in the Min mouse. Cancer Lett. 2000;159(1):57–62
  35. Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002;11(6):535–540
  36. Cooke D, Schwarz M, Boocock D, Winterhalter P, Steward WP, Gescher AJ, et al. Effect of cyanidin-3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis–relationship with tissue anthocyanin levels. Int J Cancer. 2006;119(9):2213–2220
  37. Shen G, Khor TO, Hu R, Yu S, Nair S, Ho CT, et al. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res. 2007;67(20):9937–9944
  38. Bose M, Hao X, Ju J, Husain A, Park S, Lambert JD, et al. Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (−)-epigallocatechin-3-gallate and fish oil. J Agric Food Chem. 2007;55(19):7695–7700
  39. Petrik MB, McEntee MF, Johnson BT, Obukowicz MG, Whelan J. Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J Nutr. 2000;130(10):2434–2443
  40. Oikarinen SI, Pajari AM, Salminen I, Heinonen SM, Adlercreutz H, Mutanen M. Effects of a flaxseed mixture and plant oils rich in alpha-linolenic acid on the adenoma formation in multiple intestinal neoplasia (Min) mice. Br J Nutr. 2005;94(4):510–518
  41. Oikarinen SI, Pajari A, Mutanen M. Chemopreventive activity of crude hydroxsymatairesinol (HMR) extract in Apc(Min) mice. Cancer Lett. 2000;161(2):253–258
  42. Davis CD, Zeng H, Finley JW. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr. 2002;132(2):307–309
  43. Hu R, Khor TO, Shen G, Jeong WS, Hebbar V, Chen C, et al. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis. 2006;27(10):2038–2046
  44. Cai H, Al-Fayez M, Tunstall RG, Platton S, Greaves P, Steward WP, et al. The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice. Mol Cancer Ther. 2005;4(9):1287–1292
  45. Sang S, Ju J, Lambert JD, Lin Y, Hong J, Bose M, et al. Wheat bran oil and its fractions inhibit human colon cancer cell growth and intestinal tumorigenesis in Apc(min/+) mice. J Agric Food Chem. 2006;54(26):9792–9797
  46. Rajakangas J, Misikangas M, Päivärinta E, Mutanen M. Chemoprevention by white currant is mediated by the reduction of nuclear beta-catenin and NF-kappaB levels in Min mice adenomas. Eur J Nutr. 2008;47(3):115–122
  47. Mandir N, Englyst H, Goodlad RA. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc mouse model of intestinal cancer, association with enhanced polyp development. Br J Nutr. 2008;1–11
  48. Wasan HS, Novelli M, Bee J, Bodmer WF. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc Natl Acad Sci U S A. 1997;94(7):3308–3313
  49. Mollersen L, Paulsen JE, Olstorn HB, Knutsen HK, Alexander J. Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice. Carcinogenesis. 2004;25(1):149–153
  50. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939–1951
  51. Kim DJ, Shin DH, Ahn B, Kang JS, Nam KT, Park CB, et al. Chemoprevention of colon cancer by Korean food plant components. Mutat Res. 2003;523-524:99–107[Review]
  52. Special Diet Services . "Rat and Mouse No.1 Maintenance." Lab Animals. Special Diet Services. http://www.labanimals.no/ADFDmiljofaktorer/RM1.pdf2008;
  53. Kang SY, Seeram NP, Nair MG, Bourquin LD. Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation of human colon cancer cells. Cancer Lett. 2003;194(1):13–19
  54. Mutanen M, Pajari AM, Oikarinen SI. Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to beta-catenin and PKC isozymes. Carcinogenesis. 2000;21(6):1167–1173
  55. Ushida Y, Sekine K, Kuhara T, Takasuka N, Iigo M, Tsuda H. Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse. Cancer Lett. 1998;134(2):141–145
  56. Huerta S, Irwin RW, Heber D, Go VL, Moatamed F, Huerta S, et al. Intestinal polyp formation in the Apcmin mouse: effects of levels of dietary calcium and altered vitamin D homeostasis. Dig Dis Sci. 2003;48(5):870–876
  57. Mandir N, Goodlad RA. Conjugated linoleic acids differentially alter polyp number and diameter in the Apc(min/+) mouse model of intestinal cancer. Cell Prolif. 2008;41(2):279–291
  58. Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 2005;65(22):10623–10631
  59. Paulsen JE, Elvsaas IK, Steffensen IL, Alexander J. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis. 1997;18(10):1905–1910
  60. Oikarinen S, Heinonen SM, Nurmi T, Adlercreutz H, Mutanen M. No effect on adenoma formation in Min mice after moderate amount of flaxseed. Eur J Nutr. 2005;44(5):273–280
  61. Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim YI. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/−Msh2−/− mice. Cancer Res. 2000;60(12):3191–3199
  62. van Kranen HJ, van Iersel PW, Rijnkels JM, Beems DB, Alink GM, van Kreijl CF. Effects of dietary fat and a vegetable-fruit mixture on the development of intestinal neoplasia in the ApcMin mouse. Carcinogenesis. 1998;19(9):1597–1601
  63. Ziegler CC, Rainwater L, Whelan J, McEntee MF. Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice. J Nutr. 2004;134(1):5–10
  64. Walzem R, Clifford A. Folate deficiency in rats fed diets containing free amino acids or intact proteins. J. Nutr. 1988;118:1089–1096
  65. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med. 2003;54:131–152[Review]
  66. Bartram HP, Gostner A, Reddy BS, et al. Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high fat diet; potential role of the n3:n6 fatty acid ratio. Eur J Cancer Prev. 1995;4:231–237
  67. Clarke JD, Dashwood RH, Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 2008;269(2):291–304
  68. Frydoonfar HR, McGrath DR, Spigelman AD. Sulforaphane inhibits growth of a colon cancer cell line. Colorectal Dis. 2004;6(1):28–31
  69. Landis-Piwowar KR, Milacic V, Dou QP. Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells. J Cell Biochem. 2008;105(2):514–523
  70. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631–1652[Review]
  71. Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 2007;255(2):170–181
  72. Lin CC, Lu YP, Lou YR, Ho CT, Newmark HH, MacDonald C, et al. Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA-DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice. Cancer Lett. 2001;168(2):125–132
  73. Johnson IT, Lund EK. Review article: nutrition, obesity and colorectal cancer. Aliment Pharmacol Ther. 2007;26(2):161–181
  74. Mayne ST, Graham S, Zheng TZ. Dietary retinol: prevention or promotion of carcinogenesis in humans?. Cancer Causes Control. 1991;2(6):443–450[Review]
  75. Jacobasch G, Dongowski G, Florian S, Müller-Schmehl K, Raab B, Schmiedl D. Pectin does not inhibit intestinal carcinogenesis in APC-deficient Min/+ mice. J Agric Food Chem. 2008;56(4):1501–1510
  76. Oshima M, Takahashi M, Oshima H, Tsutsumi M, Yazawa K, Sugimura T, et al. Effects of docosahexaenoic acid (DHA) on intestinal polyp development in Apc delta 716 knockout mice. Carcinogenesis. 1995;16(11):2605–2607
  77. Hioki K, Shivapurkar N, Oshima H, Alabaster O, Oshima M, Taketo MM. Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(delta716) knockout mice. Carcinogenesis. 1997;18(10):1863–1865
  78. Crim KC, Sanders LM, Hong MY, Taddeo SS, Turner ND, Chapkin RS, et al. Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet. Carcinogenesis. 2008;29(7):1415–1420
  79. Yang WC, Mathew J, Velcich A, Edelmann W, Kucherlapati R, Lipkin M, et al. Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res. 2001;61(2):565–569
  80. Kearney J, Giovannucci E, Rimm EB, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol. 1996;143:907–917
  81. McCullough ML, Robertson AS, Rodriguez C, et al. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control. 2003;14:1–12
  82. Cho E, Smith-Warner SA, Spiegelman D, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst. 2004;96:1015–1022
  83. Augenlicht LH, Anthony GM, Church TL, Edelmann W, Kucherlapati R, Yang K, et al. Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. Cancer Res. 1999;59(23):6005–6009
  84. Reitmair AH, Redston M, Cai JC, Chuang TCY, Bjerknes M, Cheng H, et al. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res. 1996;56:3842–3849
  85. Peltomaki P. DNA mismatch repair and cancer. Mutat Res. 2001;488(1):77–85
  86. Sauer J, Mason JB, Choi SW. Too much folate: a risk factor for cancer and cardiovascular disease?. Curr Opin Clin Nutr Metab Care. 2009;12(1):30–36
  87. Mizoguchi A, Mizoguchi E, Saubermann LJ, Higaki K, Blumberg RS, Bhan AK. Limited CD4 T-cell diversity associated with colitis in T-cell receptor alpha mutant mice requires a T helper 2 environment. Gastroenterology. 2000;119:983–995
  88. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL12- and gamma interferon-dependent mechanism. Infect Immun. 1998;66:5157–5166
  89. Garrelds IM, van Meeteren ME, Meijssen MAC, Zikjlsra FJ. Interleukin-2-deficient mice: effect on cytokines and inflammatory cells in chronic colonic disease. Dig Dis Sci. 2002;47:503–510
  90. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, et al. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Gen. 1995;10:143–150
  91. Seril DN, Liao J, Yang CS, Yang GY. Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet. Dig Dis Sci. 2005;50(4):696–707
  92. Wurzelmann JI, Silver A, Schreinemachers DM, et al. Iron Intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1996;5:503–507
  93. Lee DH, Anderson KE, Harnack LJ, et al. Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. J Natl Cancer Inst. 2004;96:403–407
  94. Hegazi RA, Saad RS, Mady H, Matarese LE, O'Keefe S, Kandil HM. Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice. Nutrition. 2006;22(3):275–282
  95. Hall MN, Chavarro JE, Lee IM, Willett WC, Ma J. A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1136–4398
  96. Nones K, Dommels YE, Martell S, Butts C, McNabb WC, Park ZA, et al. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a−/−) mice, a model of inflammatory bowel diseases. Br J Nutr. 2009;101(2):169–181
  97. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1325–1329
  98. Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A, et al. Romagnolo B.Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res. 2006;66(4):1949–1955
  99. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, et al. Evolution of mammals and their gut microbes. Science. 2008;320(5883):1647–1651
  100. O'Neill P. “Other Tests You Might be Given.” Colorectal cancer guide. WebMD. 4 Aug 2008. http://www.webmd.com/colorectal-cancer/guide/tests-given-colorectal-cancer2007;

PII: S0955-2863(09)00217-4

doi: 10.1016/j.jnutbio.2009.09.014

The Journal of Nutritional Biochemistry
Volume 21, Issue 2 , Pages 77-88 , February 2010